Literature DB >> 22559754

The contribution of different information sources for adverse effects data.

Su Golder1, Yoon K Loke.   

Abstract

OBJECTIVES: The aim of this study is to determine the relative value and contribution of searching different sources to identify adverse effects data.
METHODS: The process of updating a systematic review and meta-analysis of thiazolidinedione-related fractures in patients with type 2 diabetes mellitus was used as a case study. For each source searched, a record was made for each relevant reference included in the review noting whether it was retrieved with the search strategy used and whether it was available but not retrieved. The sensitivity, precision, and number needed to read from searching each source and from different combinations of sources were also calculated.
RESULTS: There were 58 relevant references which presented sufficient numerical data to be included in a meta-analysis of fractures and bone mineral density. The highest number of relevant references were retrieved from Science Citation Index (SCI) (35), followed by BIOSIS Previews (27) and EMBASE (24). The precision of the searches varied from 0.88% (Scirus) to 41.67% (CENTRAL). With the search strategies used, the minimum combination of sources required to retrieve all the relevant references was; the GlaxoSmithKline (GSK) website, Science Citation Index (SCI), EMBASE, BIOSIS Previews, British Library Direct, Medscape DrugInfo, handsearching and reference checking, AHFS First, and Thomson Reuters Integrity or Conference Papers Index (CPI).
CONCLUSIONS: In order to identify all the relevant references for this case study a number of different sources needed to be searched. The minimum combination of sources required to identify all the relevant references did not include MEDLINE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559754     DOI: 10.1017/S0266462312000128

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

1.  Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.

Authors:  Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

2.  An assessment of the efficacy of searching in biomedical databases beyond MEDLINE in identifying studies for a systematic review on ward closures as an infection control intervention to control outbreaks.

Authors:  Yoojin Kwon; Susan E Powelson; Holly Wong; William A Ghali; John M Conly
Journal:  Syst Rev       Date:  2014-11-11

3.  Vestibulotoxicity Associated With Platinum-Based Chemotherapy in Survivors of Cancer: A Scoping Review.

Authors:  Pattarawadee Prayuenyong; John A Taylor; Stephanie E Pearson; Rachel Gomez; Poulam M Patel; Deborah A Hall; Anand V Kasbekar; David M Baguley
Journal:  Front Oncol       Date:  2018-09-25       Impact factor: 6.244

4.  Methodological developments in searching for studies for systematic reviews: past, present and future?

Authors:  Carol Lefebvre; Julie Glanville; L Susan Wieland; Bernadette Coles; Alison L Weightman
Journal:  Syst Rev       Date:  2013-09-25

5.  The contribution of databases to the results of systematic reviews: a cross-sectional study.

Authors:  Lisa Hartling; Robin Featherstone; Megan Nuspl; Kassi Shave; Donna M Dryden; Ben Vandermeer
Journal:  BMC Med Res Methodol       Date:  2016-09-26       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.